Risk Factors and Characteristics of CRS in CAR-T Treatment
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-129777
Abstract: Background and objective Clinical trials have confirmed that CAR-T treatment has become one of the important treatments for many relapse and refractory hematological tumors. CRS is a high incidence of adverse events in CAR-T treatment.… read more here.
Keywords: crs; car; car treatment; risk factors ... See more keywords
Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1182393
Abstract: Cariprazine (CAR) is an antipsychotic drug for the treatment of schizophrenia (SCZ) and bipolar disorder (BD), and it acts as a partial agonist on the dopamine receptors (DR), D2, and D3. Although many single nucleotide… read more here.
Keywords: response car; single nucleotide; car; car treatment ... See more keywords